Pfizer Acquires Animal Health Products

The agrement covers all major animal health species including cattle, swine, equine, and companion animal. Specifically, Pfizer Animal Health will acquire from Schering-Plough a number of animal health products for sale in the European Economic Area covering the following categories:

• Swine E. coli Vaccines
• Equine Influenza and Tetanus Vaccines
• Ruminant Neonatal and Clostridia Vaccines
• Rabies Vaccines
• Companion Animal Veterinary Specialty Products
• Parasiticides & Anti-inflammatories

The acquisition is subject to certain closing conditions, including antitrust approval. Terms of the agreement were not disclosed.

Pfizer Animal Health’s Europe President, Albert Bourla, said that the acquisition will enable Pfizer Animal Health Europe to build upon its comprehensive animal health solutions for veterinarians and their clients - farmers and pet owners - in Europe.

Bourla added, “We look forward to offering veterinarians additional preventative therapies and treatments along with our technical expertise and services to ensure that animals receive the best care possible.”

Sign up for our
regular news updates

Latest Pig Industry News

•   APAS Calls for Change to Better Reflect Origin of Food Labelled "Product of Canada"
•   Fujian Boosts Quality Inspection
•   Help Needed for Surviving Livestock of Cyclone
•   RSPCA Takes Pig Action into the Classroom
•   Manure Management Webcast Coming Soon
•   Rapid On-farm FMD Test Available
•   EPP Congress 2008
•   Sponsored Walk and Climb
•   Pork Producers Get Voice On EPA Panel
•   Pork Futures: Hogs Settle Mostly Firm